Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06220656 · ClinicalTrials.gov registry record · NA

TRAIL Study: Feasibility and Pilot

A NA study of Thyroid Cancer and Thyroid Neoplasms, sponsored by Dartmouth-Hitchcock Medical Center.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06220656 is a NA study of Thyroid Cancer and Thyroid Neoplasms that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 20 participants, below the 281-participant average among 46 other Thyroid Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06220656, a NA study of Thyroid Cancer and Thyroid Neoplasms, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This is a pilot study to compare two ways of managing newly identified thyroid nodules that are likely to be cancerous based on ultrasound result and which under usual care would undergo immediate biopsy. The main goals of this pilot study are 1) compare anxiety at 6 months in each treatment arm using the validated instrument Anxiety-CA, 2) measure thyroid quality of life in each treatment arm Participants will be randomized to one of two groups: 1. immediate biopsy (usual care) 2. Active monitoring (serial ultrasound based monitoring and close clinical follow-up)

Interventions

  • PROCEDURE Biopsy
  • PROCEDURE Active Monitoring

Study Locations (1)

New Hampshire

  • Dartmouth Hitchcock Medical Center - Lebanon

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-05-01
Est. Completion 2027-06
Phase NA

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT06220656

The ClinicalTrials.gov registry entry for NCT06220656 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 281-participant average among 46 other Thyroid Cancer trials with a reported enrollment target (93% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Thyroid Cancer appearing as the primary indexed condition, and to 2 interventions - of which Biopsy is the first listed.

NCT06220656 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.

Frequently Asked Questions

What is clinical trial NCT06220656 about?

NCT06220656 is a clinical study titled "TRAIL Study: Feasibility and Pilot". This is a pilot study to compare two ways of managing newly identified thyroid nodules that are likely to be cancerous based on ultrasound result and which under usual care would undergo immediate biopsy. The main goals of this pilot study are 1) compare anxiety at 6 months in each treatment arm us...

What is the current status of trial NCT06220656?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-05-01. Estimated completion is 2027-06.

What conditions does trial NCT06220656 study?

This clinical trial studies the following conditions: Thyroid Cancer, Thyroid Neoplasms, Thyroid Nodule.

What interventions are being tested in trial NCT06220656?

The interventions under investigation include: Biopsy (PROCEDURE), Active Monitoring (PROCEDURE).

Who is sponsoring clinical trial NCT06220656?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06220656 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thyroid Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.